Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice
- PMID: 9199458
- PMCID: PMC175400
- DOI: 10.1128/iai.65.7.2846-2851.1997
Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice
Abstract
Inoculation of severe combined immunodeficient (SCID) mice with microfilariae of Onchocerca lienalis results in a sustained infection of the skin, extending for months beyond the point at which the parasites are eliminated from immunocompetent BALB/c controls. Reconstitution of SCID mice with spleen cells, thymocytes, or CD4+-cell-enriched splenocytes from naive BALB/c donors confers the ability to mount a protective immune response, leading to the rapid elimination of microfilariae. High levels of interleukin-5 and low levels of gamma interferon in the sera of reconstituted SCID mice during the destruction of microfilariae suggest that this protective immune response is directed by Th2 lymphocytes, mirroring that observed in immunocompetent controls. Unexpectedly, abbreviation of primary infections of unreconstituted SCID mice with the drug ivermectin induces resistance to reinfection with microfilariae at a level equivalent to that induced in secondarily infected, immunocompetent controls. In contrast to protection mediated by adoptive reconstitution, resistance induced by ivermectin-abbreviated infection occurs in the absence of T cells and in association with negligible levels of serum interleukin-5 and gamma interferon. This points to the activation of some alternative host defense mechanism that operates after the clearance of therapeutic levels of drug. Such a response could have important implications for the treatment of human onchocerciasis and may go some way in explaining the long-term suppression of microfilariae observed in patients after treatment with ivermectin.
Similar articles
-
Roles for both CD4+ and CD8+ T cells in protective immunity against Onchocerca lienalis microfilariae in the mouse.Parasite Immunol. 1995 Oct;17(10):541-53. doi: 10.1111/j.1365-3024.1995.tb00885.x. Parasite Immunol. 1995. PMID: 8587792
-
IL-5 dominates cytokine responses during expression of protective immunity to Onchocerca lienalis microfilariae in mice.Parasite Immunol. 1999 Feb;21(2):81-8. doi: 10.1046/j.1365-3024.1999.00204.x. Parasite Immunol. 1999. PMID: 10101718
-
Transfer of immunity to the microfilariae of Onchocerca lienalis in mice.Trop Med Parasitol. 1987 Dec;38(4):283-6. Trop Med Parasitol. 1987. PMID: 3502031
-
CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.Int J Parasitol. 2003 Sep 30;33(11):1161-71. doi: 10.1016/s0020-7519(03)00170-x. Int J Parasitol. 2003. PMID: 13678632 Review.
-
[Molecular approaches to the control of onchocerciasis in Mexico].Rev Latinoam Microbiol. 2005 Jul-Dec;47(3-4):112-29. Rev Latinoam Microbiol. 2005. PMID: 17061536 Review. Spanish.
Cited by
-
Tropomyosin implicated in host protective responses to microfilariae in onchocerciasis.Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7550-5. doi: 10.1073/pnas.95.13.7550. Proc Natl Acad Sci U S A. 1998. PMID: 9636187 Free PMC article.
-
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.Parasit Vectors. 2014 Oct 24;7:472. doi: 10.1186/s13071-014-0472-z. Parasit Vectors. 2014. PMID: 25338621 Free PMC article.
-
Examining the role of macrolides and host immunity in combatting filarial parasites.Parasit Vectors. 2017 Apr 14;10(1):182. doi: 10.1186/s13071-017-2116-6. Parasit Vectors. 2017. PMID: 28410595 Free PMC article. Review.
-
Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate against Onchocerciasis and Related Filarial Diseases.Pathogens. 2021 Jan 21;10(2):99. doi: 10.3390/pathogens10020099. Pathogens. 2021. PMID: 33494344 Free PMC article.
-
Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis.Clin Exp Immunol. 1999 Oct;118(1):95-101. doi: 10.1046/j.1365-2249.1999.01021.x. Clin Exp Immunol. 1999. PMID: 10540165 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials